| Model Number |
CTB71 |
| Medical Device Problem Code |
Break (1069)
|
| Health Effect - Clinical Code |
No Consequences Or Impact To Patient (2199)
|
| Date of Event |
08/16/2016
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Ra has received the incident device and the product has been assigned to engineering for evaluation.A follow-up report will be sent upon completion of the investigation.There is no report of serious injury or death associated with this event.
|
| |
|
Event or Problem Description
|
|
By-pass + cholecystectomy - "nature of incident: the tip of the trocar broke during the intervention in the patient's abdomen." additional information from sales rep sent august 17, 2016: there is no information on how the fracture occurred.The surgeon noticed the fracture at the end of the procedure when he wanted to remove the trocar.The fracture was a clean break and the port was used as an ancillary port.It was a standard method of insertion knowing that this is a bladed trocar.Patient status - "patient is ok".Type of intervention - "consequences: the surgeon immediately removed the trocar and managed to recover the broken tip.".
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information was requested from the customer and provided.Investigation summary: the event unit was returned for evaluation.Upon inspection, engineering confirmed the cannula was fractured.The root cause of this incident is likely due to manufacturing.Engineering took dimensional measurements of the wall thickness of the cannula and found that the wall thickness did not meet specifications.Engineering believes the fracture observed could have been a result of this uneven wall thickness.Applied medical continuously seeks to improve the form, function and ease of use of its products.As part of this continuous process, applied medical is currently researching possible process enhancements intended to further minimize the potential for this type of event to occur.In accordance to 21 cfr 803.56, if we obtain additional information, which was not known or was not available when this report was submitted, then a supplemental report will be submitted to the fda.
|
| |
|
Search Alerts/Recalls
|